Key Takeaways

• Discovery acquired Icario Holdco for $27 million, with potential additional payments up to $32.5 million based on performance.
• The acquisition strengthens Discovery’s position in the US government-sponsored health plans, covering around 11 million lives.
• This purchase is part of Discovery’s broader strategy to expand its AI and health technology presence in key global markets.

Discovery Expands into US Health Technology

Discovery Holdings is deepening its investment in the US healthcare sector through its subsidiary, Vitality Group International. On September 1, two days before announcing its annual financial results, Discovery completed the acquisition of Icario Holdco. Icario, a healthcare services company, specializes in creating member engagement tools targeted at government-funded health plans in the US.

The total cost of the acquisition amounts to $59.5 million, with an initial payment of $27 million in cash and contingent payments of up to $32.5 million. The additional sum depends on Icario achieving specific revenue targets and growth in contracted annual recurring revenue. Importantly, the deal was conducted on a debt-free and cash-free basis, meaning Icario’s financial results will not impact Discovery’s recently released annual performance figures.

Icario’s platform reaches approximately 11 million participants in government-sponsored health plans, including Medicaid and Medicare Advantage, enhancing member interaction with healthcare services. Discovery highlighted that this acquisition boosts its capabilities in member activation, engagement, and access to additional cross-selling opportunities in the health market.

This move is the latest in a series of strategic acquisitions for Discovery in the US healthcare space. Previous transactions include the purchase of workplace wellness firm WellSpark and Ramp Health, as well as a partnership with HealthEquity, a major player in health savings accounts. VitalityHealth USA, Discovery’s health business, recorded a 22% revenue increase over the past year, expanding its service portfolio to 10 health plans and accommodating 3.6 million covered lives. The company is also advancing its “Vitality AI-enabled engagement solutions.”

Discovery’s investment in technology is not limited to the US. In Asia, Amplify Health, which Discovery co-owns, has partnered with Star Health in India to introduce AI-driven healthcare analytics and claims solutions. This expansion underscores Discovery’s goal of establishing a footprint in two of the world’s largest health markets while leveraging its existing Vitality behavioral platform.

Despite these strategic advances, Discovery’s domestic AI initiatives have incurred significant costs, with reported losses of R299 million for FY2026, marking a 200% increase. The investment in AI reflects broader objectives in customer engagement and operational enhancements, although this line also encompasses other central costs associated with the Vitality brand.

The content above is a summary. For more details, see the source article.